Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Redirecting T lymphocyte specificity using T cell receptor genes.

Barbara L F Kaplan1, David C Yu, Timothy M Clay

  • 1Department of Surgery, University of Chicago, Chicago, Illinois 60637, USA.

International Reviews of Immunology
|May 15, 2003
PubMed
Summary

Redirecting T cells using tumor-associated antigen (TAA)-reactive T cell receptors (TCRs) shows promise for treating cancer. This review explores TCR and chimeric immunoglobulin (cIg) gene transfer methods and challenges for patient therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of mannitol versus pertussis toxin to exacerbate active experimental autoimmune encephalomyelitis (EAE).

Journal of neuroimmunology·2026
Same author

The Positive Impacts of Mentored Summer Research Programs on Veterinary Student Career Outcomes.

Journal of veterinary medical education·2026
Same author

Indole-3-Carbinol (I3C) suppression of IgG2b-triggered signaling in innate cells involves early suppression of p-Akt.

Toxicology and applied pharmacology·2026
Same author

Clinical Factors Associated With Functional Recovery in Pediatric Traumatic Brain Injury.

The Journal of surgical research·2026
Same author

Targeting PIM2 improves antitumor immunity through promoting effector function and persistence of CD8 T cells.

The Journal of clinical investigation·2026
Same author

Demographic features, health status, and behavioral changes associated with cannabidiol use in the Dog Aging Project.

Frontiers in veterinary science·2025

Area of Science:

  • Immunology
  • Cancer Therapy
  • Gene Therapy

Background:

  • T cell receptor (TCR) gene transfer can redirect T cell specificity.
  • Tumor-associated antigens (TAAs) are targets for cancer immunotherapy.
  • Peripheral blood lymphocytes (PBLs) are a source of T cells for genetic modification.

Purpose of the Study:

  • To review recent studies on redirecting T cell specificity using TCR and chimeric immunoglobulin (cIg) gene transfer.
  • To discuss the therapeutic potential of these approaches for diseases like cancer.
  • To identify technical and biological hurdles for clinical application.

Main Methods:

  • Retroviral gene transfer of TCR alpha and beta chain genes.
  • Engineering chimeric immunoglobulin (cIg) genes with signaling domains (CD3 zeta or Fc epsilon RI-gamma).

Related Experiment Videos

  • Evaluation of studies using TCRs and cIgs to redirect T cell specificity.

    • Main Results:

    • TCR and cIg gene transfer can alter T cell specificity towards TAAs.
    • These engineered T cells hold therapeutic potential for cancer treatment.
    • Various studies demonstrate the feasibility of redirecting T cell function.

    Conclusions:

    • Redirecting T cells via TCR and cIg gene transfer is a promising strategy for cancer immunotherapy.
    • Overcoming technical and biological challenges is crucial for successful clinical translation.
    • Further research is needed to optimize these gene-based T cell therapies.